LIAISON CMV IgG Avidity II - SFDA Registration ME0000003094SFDAA00052
Access comprehensive regulatory information for LIAISON CMV IgG Avidity II in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List B device is registered with Saudi Arabia SFDA under registration number ME0000003094SFDAA00052 and manufactured by DiaSorin S.p.A..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
IVD Kit determination of antigen binding avidity of IgG antibodies to hCMV in human serum or plasma
The LIAISON® CMV IgG Avidity II assay uses chemiluminescence immunoassay (CLIA) technology for the determination of antigen-binding avidity of IgG antibodies to hCMV in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family.
[]